When You Need Specialized Expertise for Your Pulmonary Research
PRC Clinical Is the Right Clinical Research Organization for Your Next Pulmonary Trial
As the recent pandemic has highlighted, pulmonary clinical research is essential. COVID-19 has forever changed the clinical research landscape, creating high demand for respiratory therapies including intervention studies for high-risk patients and vaccine trials.
With extensive experience carrying out pulmonary clinical research and remote monitoring capabilities, PRC Clinical is set up to accommodate early phase studies including Phase I and Phase II through Phase III trials, whether COVID-19-related or not.
Pulmonary by the Numbers
Respiratory card device market is projected to expand at a compound annual growth rate of 12.5% over the next five years. (Source)
You Deserve Pulmonary Therapeutic Expertise
- Idiopathic Pulmonary Fibrosis (IPF)
- Pulmonary Arterial Hypertension (PAH)
We understand the need to be prepared for anything. Relying on our existing business continuity plans, PRC was able to immediately respond to the needs of our clients to maintain trial momentum. When the COVID-19 pandemic began, we were capable of quickly modifying long-term plans, best practices, and permanent use. Our flexible team is dedicated to working closely with you to create personalized strategies and customized solutions to navigate current challenges, including remote monitoring, decentralized trial support for vaccine trials, and more.